Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I–IV
Introduction
Drugs intended for oral administration must be sufficiently hydrophilic to dissolve in gastrointestinal (GI) fluids; yet, they must also possess sufficient hydrophobic character to undergo passive transport across intestinal epithelia. It is generally accepted that transcellular passive diffusion is the most significant transport mechanism for intestinal drug absorption, and the rate of transport is determined by the physicochemical properties of the epithelium as well as the properties of the solute itself (Adson et al., 1995, Daugherty and Mrsny, 1999). In vitro models used to investigate drug transport, such as the Caco-2 and MDCK cell lines, differentiate into columnar epithelia and form tight junctions when cultured on semi-permeable membranes (Cereijido et al., 1978, Cho et al., 1989, Hidalgo et al., 1989). These types of cell monolayers are widely used in drug discovery settings in order to rank lead candidates with respect to their potential rate of absorption in vivo (Hidalgo et al., 1989, Artursson and Karlsson, 1991, Artursson and Borchardt, 1997, Irvine et al., 1999).
Caco-2 cells express several transporters, including P-glycoprotein, and interpretation of apparent permeability (Papp) data can in certain cases be fairly complex (Burton et al., 1993). In addition to their relatively long maturation time and subsequent high risk of infection, Caco-2 cultures consist of a heterogeneous mixture of subtypes and display a well-established lack of inter-experimental reproducibility (Hidalgo et al., 1989, Artursson and Borchardt, 1997). In this study, since only passive diffusion is considered, an absorption model without these complicating factors was preferred; thus, the MDCK Strain I cell line was used (Irvine et al., 1999). Caco-2 and MDCK cell lines demonstrate similar Papp values for passively absorbed drugs (Raub et al., 1993, Irvine et al., 1999), and a recent comparison of drug Papp vs. human intestinal absorption concluded that MDCK monolayers are in fact slightly more predictive of in vivo absorption vs. Caco-2 (Irvine et al., 1999). MDCK monolayers possess other advantages over Caco-2: a significantly shorter maturation time in culture, and thus less chance for infection to occur; relatively low expression of P-gp, if only passive transport is to be determined (Horio et al., 1989); and morphologic homogeneity, resulting in inter-laboratory reproducibility (Cho et al., 1989, Irvine et al., 1999). Two sub-types of MDCK cells are available: Strain I, which matures into tight monolayers with transepithelial electrical resistance (TEER) >1500 Ω cm2; and Strain II, which matures into monolayers displaying a TEER of 100–300 Ω cm2 (Cho et al., 1989). MDCK Strain I cells can easily be grown on permeable polycarbonate supports and form a confluent, highly polarized monolayer within 5 days that mimics intestinal enterocytes and provides a convenient model for studying drug Papp (Cho et al., 1989, Raub et al., 1993, Irvine et al., 1999).
A drug’s aqueous solubility is a factor dictating its dissolution rate under given pH conditions and thus the amount of drug available for absorption (Amidon et al., 1995, Charman et al., 1997, Dressman et al., 1998). Low aqueous solubility at physiological pH values is therefore likely to result in poor absorption; consequently, even the presence of a high rate of permeation may not facilitate absorption if the compound possesses poor solubility. Conversely, a compound with high aqueous solubility might be well absorbed even if it demonstrates a moderate or low permeation rate (Artursson and Borchardt, 1997, Lipinski, 2000). Screening the aqueous solubility of large numbers of compounds necessitates a departure from traditional, time- and resource-consuming methods that accurately measure thermodynamic solubility (Lipinski, 2000). Nephelometry, which measures the point of precipitation at various pH values and under controlled temperatures, results in a reliable, quick, and reproducible screening system for accurately estimating solubility in the μg/ml range.
The Biopharmaceutics Classification System (BCS) is a recently developed guidance framework that classifies immediate release (IR) drug substances based on their aqueous solubility and transcellular Papp as a basis for establishing an in vitro–in vivo correlation (IVIVC), which can be extrapolated to estimate a drug’s rate and extent of GI absorption (Amidon et al., 1995, Fleisher et al., 1999). Relatively little information is available regarding the effects of various excipients or solvents on compound Papp when measured in vitro (Aungst et al., 2000). Thus, investigation of various buffer/excipient systems compatible with in vitro Papp experiments, using compounds representative of the four BCS classes, would assist in ascertaining which in vitro protocols provide the most reliable estimate of in vivo Papp for discovery-based compounds that could potentially fall into any of the four BCS classes.
Section snippets
Materials
MDCK Strain I cells were kindly donated by Dr. Wei-Chiang Shen (Los Angeles, CA, USA). All cell culture reagents were purchased from Life Technologies (Taastrup, Denmark), unless otherwise noted. [14C]Mannitol was purchased from Amersham International (Buckinghamshire, UK), and [14C]testosterone, [3H]verapamil and [3H]digoxin were purchased from NEN Life Science Products (Boston, MA, USA). Acetaminophen, acyclovir, amphotericin B, chlorothiazide, danazol, digoxin, furosemide, ketoprofen,
Turbidimetric solubility determination
Acetaminophen, ketoprofen, midazolam, verapamil (class I) and acyclovir and furosemide (class III) demonstrated solubilities ≥100 μg/ml at pH 6.0 and 7.4 in HBSS. Additionally, digoxin (class II) and chlorothiazide (class IV) also demonstrated estimated solubilities ≥100 μg/ml. As is shown in the HBSS (control) column of Table 1, amphotericin B (class IV), danazol, and phenytoin (class II) demonstrate turbidimetric solubilities <50 μg/ml. Mefenamic acid (class II) was soluble at 80 μg/ml at pH
Discussion
In many small molecule lead identification programs throughout the biopharmaceutical industry, potent lead candidates often present challenges to discovery scientists with respect to determining their “drug-like” properties (Artursson and Borchardt, 1997, Curatolo, 1998, Lipinski, 2000). Various in vitro assays are employed, often including the determination of Papp and solubility. Proper interpretation of these data is of considerable importance, and one of the principal challenges is to be
References (27)
- et al.
Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers
J. Pharm. Sci.
(1995) - et al.
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
Biochem. Biophys. Res. Commun.
(1991) - et al.
Evidence for a polarised efflux system for peptides in the apical membrane of Caco-2 cells
Biochem. Biophys. Res. Commun.
(1993) - et al.
Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH
J. Pharm. Sci.
(1997) Physical chemical properties of oral drug candidates in the discovery and exploratory development settings
Pharm. Sci. Technol. Today
(1998)- et al.
Transcellular uptake mechanisms of the intestinal epithelial barrier. Part one
Pharm. Sci. Technol. Today
(1999) - et al.
Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
Gastroenterology
(1989) - et al.
Transepithelial transport of drugs by the multidrug transporter in cultured Madin–Darby canine kidney cell epithelia
J. Biol. Chem.
(1989) - et al.
MDCK (Madin–Darby canine kidney) cells: a tool for membrane permeability screening
J. Pharm. Sci.
(1999) Drug-like properties and the cause of poor solubility and poor permeability
J. Pharmacol. Toxicol. Methods
(2000)
Link between drug absorption solubility and permeability measurements in Caco-2 cells
J. Pharm. Sci.
Bioavailability of chlorothiazide tablets in humans
J. Pharm. Sci.
Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells
Eur. J. Pharm. Sci.
Cited by (63)
Identification of the primary determining factor(s) governing the oral absorption of edaravone in rats
2018, European Journal of Pharmaceutical SciencesCitation Excerpt :In this study, the final concentration of the organic solvent (e.g., DMSO) in the transport buffer was fixed at 0.1% in all experiments. In our previous study, it was found that concentrations of DMSO of up to 2% in the transport medium had no appreciable effect on the function of the MDCKII cells expressing drug transporter (Yim et al., 2017), consistent with other literature findings (Da Violante et al., 2002; Taub et al., 2002). An aliquot (300 μL for apical chamber or 500 μL for basolateral chamber) of the media was collected from the receiver chamber at 120 min.
Automated assays for thermodynamic (equilibrium) solubility determination
2018, Drug Discovery Today: TechnologiesCitation Excerpt :The final DMSO concentration varies with the specific assay protocol and can range from 0.33% to 5% [7–10,13,18–21]. In principle, the concentration of DMSO should be kept to an absolute minimum (≤1%) to minimise the impact of any co-solvent effects, as the amount of DMSO can influence the solubility of the substance in a highly compound-dependent and unpredictable manner [6,18,21]. In one study, the presence of DMSO in concentrations of 0.33%–5% barely increased the solubility of chlorpromazine, while the solubility of warfarin was dramatically increased in the presence of 0.33% DMSO [18].
BCS class IV drugs: Highly notorious candidates for formulation development
2017, Journal of Controlled ReleaseCurcumin, bisdemethoxycurcumin and dimethoxycurcumin complexed with cyclodextrins have structure specific effect on the paracellular integrity of lung epithelia in vitro
2015, Biochemistry and Biophysics ReportsCitation Excerpt :Additionally, previous limitations with the use of curcumin is its poor solubility at acid and physiological pH and rapid hydrolysis at basic pH [25]. This results in the use of DMSO and/or ethanol as a solvents [22,23,26], which can have adverse effects on the investigated cells [27,28]. By complexing curcumins with cyclodextrins (CDs) in aqueous solutions [29,30], the solubility and stability can be increased [30,31].
Intestinal uptake and toxicity evaluation of acetazolamide and its multicomponent complexes with hidroxypropyl-β-cyclodextrin in rats
2015, International Journal of PharmaceuticsCitation Excerpt :However, the precise mechanisms that control the processes of its intestinal transport still remain to be elucidated. Despite the high oral bioavailability of ACZ, Lindenberg et al. (2004) tentatively classified ACZ as Class IV of the Biopharmaceutics Classificaiton Systems (BCS) (Amidon et al., 1995; Taub et al., 2002), indicative of low solubility and low permeability. Later, Wu and Benet (2005) classified ACZ as Class IV in their Biopharmaceutics Drug Disposition Classification System (BDDCS).